Breast Cancer Surveillance Consortium (BCSC): A Research Infrastructure sponsored by the National Cancer Institute Breast Cancer Risk Models William Barlow,

Slides:



Advertisements
Similar presentations
Which of the following increases a women’s risk for Breast Cancer? A.Starting her menses at age 14 or older B.Breastfeeding C.Extremely dense breast tissue.
Advertisements

†Source: U.S. Cancer Statistics Working Group. United States Cancer Statistics: 1999–2011 Incidence and Mortality Web-based Report. Atlanta (GA): Department.
Controversies in Breast Cancer Allan Arkush, DO, FACOS.
Breast MR Imaging Workshop th September 2014 High-Risk Screening Evidence-based Clinical Indications for Breast MRI Dr. Muhamad Zabidi Ahmad, AMDI.
National Mammography Database
Breast Density A patient guide.
Breast Cancer Risk and Risk Assessment Models
Meta-Analysis of PSA Growth Lurdes Y.T. Inoue, Ph.D. Ruth Etzioni, Ph.D. Elizabeth Slate, Ph.D. Christopher Morrel, Ph.D.
Anthropometry and Breast Cancer Publication van den Brandt, P.A., et al. Pooled analysis of prospective cohort studies on height, weight and breast cancer.
Alcohol and Breast Cancer Publications Smith-Warner, S.A., et al. Alcohol and breast cancer in women: a pooled analysis of cohort studies. JAMA. 1998;
Statistics for Health Care
Every Woman, Every Time: Disparities in Breast Cancer Tony L. Weaver, D.O. ALOMA 2015.
Breast Imaging Made Brief and Simple
By Rachel, Xiao Xia, Helen. Introduction Definition Symptoms Causes Prevention Treatment Prognosis Statistics Conclusion.
Breast Cancer screening in the NHS Dr D J Rohan Subasinghe.
® Introduction Low Back Pain Remedies and Procedures: Helpful or Harmful? Lauren Lyons, Terrell Benold, MD, Sandra Burge, PhD The University of Texas Health.
Volumetric Breast Density understandbreastdensity.or g.
NON-STEROIDAL ANTI-INFLAMMATORY DRUGS AND PANCREATIC CANCER RISK: A NESTED CASE-CONTROL STUDY Marie Bradley, Carmel Hughes, Marie Cantwell and Liam Murray.
Genomics Alexandra Hayes. Genomics is the study of all the genes in a person, as well as the interactions of those genes with each other and a person’s.
Knowledge, Cancer Fatalism and Spirituality as Predictors of Breast Cancer Screening Practices for African American and Caucasian Women Staci T. Anderson,
Racial/Ethnic Disparities in Cancer Incidence, Survival and Treatment Linda C. Harlan, PhD, MPH National Cancer Institute Division of Cancer Control and.
Epidemiology of Breast Cancer Selected Highlights Jack Cuzick, Ph.D Cancer Research UK London.
Bayesian Network for Predicting Invasive and In-situ Breast Cancer using Mammographic Findings Jagpreet Chhatwal1 O. Alagoz1, E.S. Burnside1, H. Nassif1,
Extending the Gail model for Breast Cancer Risk Prediction to Account for Modifiable Factors in the Italian Population. Calza S, Ferraroni M, Decarli A.
Mastectomy 16gene.html (article) 16gene.html
1 Breast Cancer Risk Prediction Bernard Rosner Impact of Time-Dependent Risk Factors and Heterogeneity by ER/PR Receptor Status.
1 Journal Club Alcohol, Other Drugs, and Health: Current Evidence January–February 2014.
Menopause: The Journal of The North American Menopause Society
UOG Journal Club: January 2013
Director, NIH Division of Nutrition Research Coordination
Criteria for Assessment of Performance of Cancer Risk Prediction Models: Overview Ruth Pfeiffer Cancer Risk Prediction Workshop, May 21, 2004 Division.
Risk Prediction in Clinical Practice Joann G. Elmore MD, MPH SCCA June 11, 2014.
Outcomes of screening mammography among women aged 40 to 43 Institute for Clinical Evaluative Sciences Toronto, Canada (2006)
Atoosa Adibi MD. Department of Radiology Isfahan University Of Medical Sciences.
Oral Bisphosphonate and Breast Cancer: Prospective Results from the Women’s Health Initiative (WHI) Chlebowski RT et al. SABCS 2009; Abstract 21.
Breast cancer screening Diana Sarfati Director, Cancer Control and Screening Research Group.
Edward A. Sickles, M.D. Clinical Diagnostic Mammography Benchmarks.
Previous Lecture: Data types and Representations in Molecular Biology.
CISNET and BCSC: Working Together To Model The Population Impact Breast Cancer Screening A Celebration of the Work of the Breast Cancer Surveillance Consortium.
Shiva Sharma SHO to Professor Redmond.  Introduction  Increased risk groups  Consideration of genetic testing  Management of patients with mutation.
How will you approach the 35-year old, with a 2x2x2cm, firm, mobile, well-circumscribed non-tender mass on her R breast?
March 10, 2014 NURS 330 Human Reproductive Health.
Pai JK et al. N Engl J Med 2004; 351: Relative CHD risk by increasing baseline CRP plasma levels,* relative to CRP
® Introduction Changes in Opioid Use for Chronic Low Back Pain: One-Year Followup Roy X. Luo, Tamara Armstrong, PsyD, Sandra K. Burge, PhD The University.
Understanding Factors That Affect Mammography Performance: Contribution of the BCSC Bonnie C. Yankaskas, PhD Professor of Radiology University of North.
Copyright restrictions may apply Predictive Values of Psychiatric Symptoms for Internet Addiction in Adolescents: A 2-Year Prospective Study Ko C-H, Yen.
Lipoatrophy and lipohypertrophy are independently associated with hypertension: the effect of lipoatrophy but not lipohypertrophy on hypertension is independent.
Measuring and Improving Radiologists’ Interpretative Performance on Screening Mammography Karla Kerlikowske, MD Diana Buist, PhD Patricia Carney, PhD Berta.
Breast Cancer in the Women’s Health Initiative Trial of Estrogen Plus Progestin For the WHI Investigators Rowan T Chlebowski, MD., Ph.D.
Incorporating Multiple Evidence Sources for the Assessment of Breast Cancer Policies and Practices J. Jackson-Thompson, Gentry White, Missouri Cancer Registry,
Screening of diseases Dr Zhian S Ramzi Screening 1 Dr. Zhian S Ramzi.
Breast Cancer Prevention Art or Science? Kristi McIntyre M.D. Texas Oncology 2005.
Breast Cancer Surveillance Consortium: Progress in Understanding Screening Delivery and Early Detection Rachel Ballard-Barbash, MD, MPH, Associate Director,
Breast Cancer Surveillance Consortium (BCSC): sponsored by the National Cancer Institute Cancer Screening Surveillance in Clinical Practice Tracy Onega,
Using the BCSC Research Infrastructure as a Junior Investigator BCSC Meeting: Celebrating 15 Years of Accomplishment Bethesda, MD April 27, 2010 E. Shelley.
Unit 15: Screening. Unit 15 Learning Objectives: 1.Understand the role of screening in the secondary prevention of disease. 2.Recognize the characteristics.
Breast cancer affects 1 in 8 women during their lives. 1 Population Statistics.
Kevin S.Hughes, MD, FACS Co-Director, Avon Comprehensive Breast Evaluation Center Massachusetts General Hospital Surgeon The Newton-Wellesley Hospital.
Breast Density: Black, White and Shades of Gray Jen Rusiecki, MD VA Pittsburgh Health System Women’s Health Fellow AMWA Hot Topic 2016.
{ Georgia Simpson May, MS Director, Office of Health Equity Massachusetts Department of Public Health May 21, nd State of Asian Women’s Health in.
© Copyright Annals of Internal Medicine, 2016 Ann Int Med. 164 (6): ITC6-1. In the Clinic Breast Cancer Screening and Prevention.
Date of download: 6/29/2016 From: Long-Term Health Outcomes in Women With Silicone Gel Breast Implants: A Systematic Review Ann Intern Med. 2016;164(3):
Date of download: 7/7/2016 From: Genetic Risk Assessment and BRCA Mutation Testing for Breast and Ovarian Cancer Susceptibility: Systematic Evidence Review.
Mammograms and Breast Exams: When to start /stop mammograms
Breast Health Katherine B. Lee, MD, FACP April 26, 2018.
Breast Imaging Ravi Adhikary, MD.
Presenter: Wen-Ching Lan
Breast Density and Breast Cancer Risk: A Practical Review
Breast Cancer Guideline Update – Sharp Focus on Who is at Risk
Breast Cancer Screening in High-Risk Men: A 12-Year Longitudinal Observational Study of Male Breast Imaging Utilization and Outcomes Mammography screening.
Presentation transcript:

Breast Cancer Surveillance Consortium (BCSC): A Research Infrastructure sponsored by the National Cancer Institute Breast Cancer Risk Models William Barlow, PhD Senior Biostatistician, Cancer Research and Biostatistics Research Professor, Dept. of Biostatistics

 Gail model (Gail et al., JNCI, 1989)  Claus model (several references)  BRCAPRO (many references) Breast cancer risk models in 1994

 Population-based screening mammography population  Prospectively collected risk factor information coded in an uniform manner  Huge longitudinal dataset that is increasing  Can examine the very important role of breast density as a risk factor, available on almost all screening mammograms Advantage of BCSC data for estimating risk

 Barlow et al., JNCI, 2006 (77 citations)  Short-term prediction of a diagnosis of breast cancer  Tice, et al., Annals Int Med, 2008 (17 citations) Long-term prediction of a diagnosis of breast cancer Simplified model to be used in clinical care  Janes, Pepe, and Gu, Annals Int Med, 2009 (17 citations) Compares the change in risk prediction from the Gail model to the Tice model Statistical technique for evaluating how well a model improves on past models for identifying high risk individuals BCSC breast cancer risk models

 Published in the same JNCI issue as the revised Gail model which also includes breast density  Based on one million women and 2.4 million screening mammograms  Published in the same JNCI issue as the revised Gail model which also includes breast density BCSC risk prediction model

 Prospective collection of self-reported risk factors:  demographic information (age, race, ethnicity)  family history of breast cancer  previous breast procedures  menopausal status and use of hormone therapy  body mass index (BMI)  Breast density (BI-RADS scale) and mammographic assessment reported by the radiologist  Outcome is a diagnosis of breast cancer within one year of the screening mammogram  Invasive breast cancer  DCIS BCSC risk factors & outcomes

 Available online along with the risk program and documentation:   Dataset has been downloaded 228 times  What’s not included?  Mammographic outcomes; location; individual-level data  What’s missing?  genetic markers  in-depth family history assessment  environmental factors  dietary factors (other than BMI)  exercise levels BCSC risk data

 Prediction of a diagnosis of breast cancer within a year of a screening mammogram  Extrapolated to 5-years for comparison to the Gail model, but not intended for long-term prediction  Most Gail risk factors are included  Adds breast density to the risk model Purpose of the risk model

Observed incidence by age and breast density

 Risk factors for pre-menopausal and post-menopausal women are different  Required that a factor be significant to the level before including it  Goal was to keep the model as simple as possible  Develop the model on 75% and validate it on the remaining 25%  Good calibration in the validation sample (correct estimation of cancer rates)  Good prediction of individual outcomes (c-statistic) Risk model factors and assessment

Risk Model for Premenopausal Women Risk Factor LevelsOR 95% CI Age in years (versus Age 35-39) (versus Age 35-39) Age – 1.56 Age – 2.41 Age – 3.02 Prior breast procedure (versus No procedure) (versus No procedure) Yes – 1.65 Unknown – 1.10 First degree family hx (versus No family hx) (versus No family hx) Yes, 1 relative – 1.74 Yes, 2 or more relatives – 3.36 Unknown – 1.07 Breast density (BI-RADS) 1: Almost entirely fat : Scattered fibroglandular densities – : Heterogeneously dense – : Extremely dense – 6.28 Unknown/different system – 5.24 c = 0.63

Postmenopausal Predictors (c=0.62)  Age  Race  Hispanic ethnicity  Body mass index (BMI)  Age at first birth  Family history of breast cancer  Previous breast surgery  Menopausal status  Type of menopause  Hormone therapy use  Breast density  Previous screening result (false positive/true negative)

Five-year risk of invasive breast cancer based on extrapolation of the model: High and low risk women

Risk model summary  This particular model did somewhat better than the Gail model  All risk models have difficult getting beyond a c-statistic of 0.65  Still cannot identify a group of women who are risk-free  Risk models may identify high-risk groups, but still have difficulty with precise estimation of risk for a particular woman

Clinical implications  Breast density was a known risk factor, but we did not appreciate its importance relative to other risk factors  Can better estimate risk for prevention efforts  Breast density may be an early marker of a reduction in risk

Next steps  Augment the screening mammogram assessment with risk factor information to better estimate outcomes from positive or negative screening mammograms  Use changes in risk factors to develop better models of long-term risk prediction  Incorporate extensive family history and and SNPs into risk models with breast density (P01 application by BCSC)